Delphia (USA)’s Recursion Pharmaceuticals RXRX Stock Holding History

Delphia (USA)’s Portfolio RXRX Stock Details RXRX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$76.3K	Sell
2023 Q1	$177K	Buy
2022 Q3	–	Sell
2022 Q2	$149K	Buy